Athira Pharma, Inc.

NasdaqGS:ATHA Stock Report

Market Cap: US$75.5m

Athira Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:ATHA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
05 Jan 24SellUS$7,019Kevin ChurchIndividual2,412US$2.91
05 Jan 24SellUS$3,515Andrew GengosIndividual1,208US$2.91
05 Jan 24SellUS$7,019Rachel LeningtonIndividual2,412US$2.91
05 Jan 24SellUS$14,026Mark LittonIndividual4,820US$2.91
05 Jan 24SellUS$7,019Mark WorthingtonIndividual2,412US$2.91
29 Dec 23BuyUS$1,462,895Perceptive Advisors LLCCompany605,686US$2.44
07 Jun 23BuyUS$51,445Andrew GengosIndividual15,000US$3.44
05 Jun 23BuyUS$191,572Andrew GengosIndividual65,012US$3.02

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ATHA?
Owner TypeNumber of SharesOwnership Percentage
Private Companies3110.000811%
Individual Insiders2,849,0537.43%
Hedge Funds3,153,8078.23%
VC/PE Firms5,402,96414.1%
Institutions12,994,69533.9%
General Public13,925,82236.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 57.81% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.1%
Perceptive Advisors LLC
5,402,964US$10.6m12.6%0.24%
8.23%
Baker Bros. Advisors LP
3,153,807US$6.2m0%0.08%
5.18%
Richard Kayne
1,983,468US$3.9m-0.01%no data
4.43%
The Vanguard Group, Inc.
1,698,453US$3.3m0%no data
3.89%
Simplify Asset Management Inc.
1,492,792US$2.9m0%0.38%
3.89%
Propel Bio Management, LLC
1,492,792US$2.9m0%2.12%
3.01%
Tang Capital Management, LLC
1,152,715US$2.3m227%0.25%
2.35%
BML Capital Management, LLC
900,000US$1.8m-38.1%1.19%
1.73%
BlackRock, Inc.
662,662US$1.3m0.03%no data
1.19%
Millennium Management LLC
455,857US$898.0k-38.6%no data
0.97%
Pathstone Family Office, LLC
372,296US$733.4k-12.5%no data
0.9%
Dimensional Fund Advisors LP
346,804US$683.2k-35.1%no data
0.79%
Two Sigma Investments, LP
304,071US$599.0k13.9%no data
0.78%
GSA Capital Partners LLP
300,851US$592.7k1.28%0.05%
0.78%
Two Sigma Advisers, LP
298,600US$588.2k6.99%no data
0.74%
Geode Capital Management, LLC
283,327US$558.2k0%no data
0.74%
Laird Norton Tyee Trust Company
282,309US$556.2k58%0.06%
0.7%
Jacobs Levy Equity Management Inc
270,197US$532.3k-9.83%no data
0.69%
Renaissance Technologies LLC
265,400US$522.8k-6.19%no data
0.55%
Bridgeway Capital Management, LLC
212,073US$417.8k14.3%0.01%
0.47%
Pivotal BioVenture Partners LLC
180,000US$354.6k0%0.14%
0.45%
Barclays Bank PLC, Securities Investments
171,666US$338.2k-60.4%no data
0.43%
Mark Litton
164,086US$323.3k10.2%no data
0.42%
Glenna Mileson
159,930US$315.1k0%no data
0.39%
Potomac Capital Management Inc.
149,585US$294.7k101%0.52%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.